|Bid||155.52 x 1200|
|Ask||155.58 x 1200|
|Day's Range||155.26 - 157.08|
|52 Week Range||98.23 - 160.25|
|Beta (3Y Monthly)||1.14|
|PE Ratio (TTM)||46.55|
|Earnings Date||Feb 24, 2020 - Feb 28, 2020|
|Forward Dividend & Yield||N/A (N/A)|
|1y Target Est||172.40|
We know that hedge funds generate strong, risk-adjusted returns over the long run, therefore imitating the picks that they are collectively bullish on can be a profitable strategy for retail investors. With billions of dollars in assets, smart money investors have to conduct complex analyses, spend many resources and use tools that are not always […]
Masimo today announced that its management is scheduled to present at the Evercore ISI 2nd Annual HealthCONx Conference at the Four Seasons Boston Hotel on Thursday, December 5, 2019 at 11:00 a.m.
Masimo (NASDAQ: MASI) today announced that its management is scheduled to present at the Piper Jaffray 31st Annual Healthcare Conference at the Lotte New York Palace Hotel on Wednesday, December 4, 2019 at 9:30 a.m. Eastern Time. A live audiocast of the presentation will be available on the Masimo website at www.masimo.com. A replay of the audiocast will be available following the live presentation.
Digital health is committed to changing the face of healthcare as evident from its innovative solutions for the betterment of patients' lives.
Masimo announced today that in a study recently published in the Journal of Clinical Monitoring and Computing, researchers at Nippon Medical School in Tokyo, Japan u
Many investors are still learning about the various metrics that can be useful when analysing a stock. This article is...
Masimo today announced that its management is scheduled to present at the Stifel 2019 Healthcare Conference at the Lotte New York Palace Hotel on Tuesday, November 19, 2019 at 10:55 a.m.
Radius Capnography with Bluetooth® Connectivity Seamlessly Integrates Tetherless Mainstream Capnography on Root
Masimo (MASI) delivered earnings and revenue surprises of 7.04% and 3.69%, respectively, for the quarter ended September 2019. Do the numbers hold clues to what lies ahead for the stock?
Despite the ongoing US-China trade war, solid growth in emerging markets is likely to have driven the performance of the players in the medical products space this earnings season.
Masimo announced today the findings of an abstract recently presented at the American Society of Anesthesiologists 2019 Annual Meeting. In this independent study, researchers at Fukuoka University in Japan evaluated whether using Masimo SpHb® could help avoid postoperative anemia and inappropriate blood transfusion in patients undergoing total hip arthroplasty and total knee arthroplasty .1 SpHb, noninvasive, ...
Masimo (MASI) doesn't possess the right combination of the two key ingredients for a likely earnings beat in its upcoming report. Get prepared with the key expectations.
Today we'll evaluate Masimo Corporation (NASDAQ:MASI) to determine whether it could have potential as an investment...
We at Insider Monkey have gone over 730 13F filings that hedge funds and prominent investors are required to file by the SEC The 13F filings show the funds' and investors' portfolio positions as of June 28th. In this article, we look at what those funds think of Masimo Corporation (NASDAQ:MASI) based on that data. […]
HMS Holdings (HMSY) is gaining traction from growing PI and TPM analytical services as well as robust margins despite intense competition.
We've lost count of how many times insiders have accumulated shares in a company that goes on to improve markedly. On...
The collaboration with GetWellNetwork is likely to allow Cerner (CERN) in enhancing functionality for clients and patients through third-party solutions.